Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 Giugno;58(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 Giugno;58(2):224-33

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

ORIGINAL ARTICLES  


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 Giugno;58(2):224-33

lingua: Inglese

Synthesis and biological evaluation of 177Lu-DOTA-porphyrin conjugate: a potential agent for targeted tumor radiotherapy

Bhadwal M. 1, Mittal S. 1, Das T. 1, Sarma H. D. 2, Chakraborty S. 1, Banerjee S. 1, Pillai M. R. 1

1 Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai India;
2 Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai India


PDF  


A novel unsymmetrically substituted water soluble porphyrin derivative namely, 5-(p-amino­propylene­­oxyphenyl)-10,15,20-tris-(p-carboxy­methyl­ene­oxyphenyl)porphyrin was synthesized and coupled with a bifunctional chelating agent, viz. p-NCS-benzyl-DOTA (p-isothiocyanatobenzyl-1,4,7,10-tetra­aza­cyclodo­decane-1,4,7,10-tetra­acetic acid) for developing a suitable conjugate for use in targeted tumor therapy. The porphyrin-p-NCS-benzyl-DOTA conjugate was radiolabeled with 177Lu in good radiolabeling yield. Biodistribution studies performed in Swiss mice bearing fibrosarcoma tumors revealed high tumor uptake (5.33±1.11% injected activity per gm of tumor) within 30 min post-injection. The complex exhibited favorable tumor to blood and tumor to muscle ratios at various post-administration time points. Fast clearance of the non-accumulated activity was observed mostly through the renal pathway. Scintigraphic imaging studies performed in Swiss mice bearing fibrosarcoma tumors also exhibited selective accumulation of activity in the tumor.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

sharmila@barc.gov.in